Community
The latest edition
Gathering the headlines…
Connecting you to stories from original sources.
The latest edition
Gathering the headlines…
Connecting you to stories from original sources.
Your daily perspective.
World · News article
Current situation
In the United States
The risk posed by the clade I monkeypox outbreak to most people within the United States remains low.
In the United States, since November 2024, there have been more than 200 laboratory-confirmed cases of clade I monkeypox in at least 31 states plus Puerto Rico. The majority of these cases are among gay, bisexual, or other men who have sex with men. Many of these cases: Had recently traveled from areas associated with the outbreak in Central and Eastern Africa; Reported sexual contact during travel to parts of Western Europe where newer outbreaks are being reported; OR Reported sexual contact with people who had traveled from these areas.
Since August 2026, an increasing proportion of clade I cases in the United States have been reported in individuals with no recent international travel or known links to people who had recently traveled.
Cases with presumed domestic transmission have been reported in 16 jurisdictions, indicating a likely transition to sustained clade Ib transmission in the United States
CDC expects to see additional cases of both travel-related and domestically acquired cases of clade Ib occurring across the United States.
CDC continues to monitor both clade II and clade I monkeypox cases across the United States and follow surveillance reports to monitor for any changes in demographics, disease severity, or case counts by jurisdiction. CDC also continues surveillance testing to identify monkeypox clade for all specimens sent to CDC's poxvirus laboratory.
Spotlight
Jurisdictions can contact poxvirus@cdc.gov for CDC technical support and clinical consultations for severe cases Monday-Friday, 8 a.m.-5 p.m.
Clade II monkeypox is still circulating at low levels.
Fall 2025 marked the highest monthly case counts since the peak of the outbreak in 2022.
Reminder
Vaccination is an important tool in stopping the spread of monkeypox. If you have certain risk factors that make you eligible, you can help protect yourself from monkeypox by getting the 2-dose monkeypox vaccine.
Across the globe
Outbreaks of clade I monkeypox in Central and Eastern Africa continue.
Beginning in Fall 2025, several countries in Western Europe began reporting clade Ib monkeypox cases among individuals who had no documented history of international travel. These cases were likely related to male-to-male sexual contact.
Other travel-associated cases of clade I monkeypox have been reported from other parts of Africa, as well as Asia, Europe, the Middle East, North America, South America, and Australia.
Recent monkeypox outbreaks have low death rates
During recent outbreaks, death rates ranged from than less than 0.5% (clade Ib) to about 3% (clade Ia). Clade II is the type that caused the ongoing global outbreak that began in 2022. Fewer than 0.1% of people infected with clade II die from the disease.
For global case data for clade I and clade II monkeypox since January 1, 2024, see Global Mpox Trends. Confirmed cases include those that are laboratory confirmed as monkeypox virus and may include cases only confirmed as orthopoxvirus. These data are provided for situational awareness and are subject to change.
Cases of clade I monkeypox have been diagnosed worldwide.
Clade II monkeypox is spreading in the United States and around the world.